Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer have?

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer has 488 citations in the OpenAlex counts ScholarIQ stores.

When was Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer published?

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer has 2019 year in the ScholarIQ index.

What is the open-access status of Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer?

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer has green oa status in the ScholarIQ index.

What is the DOI of Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer?

The DOI for Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer is on the source record.

What is the PMID of Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer?

The PMID for Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer is on the source record.

What is the OpenAlex record for Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer?

The OpenAlex for Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer is on the source record.